Ticker Scorecard - GLYC Basics Company: GlycoMimetics, Inc. IPO Date: January 10, 2014 Sector: Healthcare Industry: Biotech Market Cap: $19.03M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 3.30% Avg Daily Range (30 D): $0.01 | 5.38% Avg Daily Range (90 D): $0.02 | 6.39% Institutional Daily Volume Avg Daily Volume: .8M Avg Daily Volume (30 D): 1.99M Avg Daily Volume (90 D): 11.27M Trade Size Avg Trade Size (Sh.): 349 Avg Trade Size (Sh.) (30 D): 559 Avg Trade Size (Sh.) (90 D): 1,183 Institutional Trades Total Inst.Trades: 330 Avg Inst. Trade: $1.69M Avg Inst. Trade (30 D): $.59M Avg Inst. Trade (90 D): $.59M Avg Inst. Trade Volume: .22M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.96M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 182.44K     News Jan 13, 2025 @ 12:00 PM Avacta Appoints Brian Hahn as Chief Financial Offi... Source: N/A Nov 5, 2024 @ 11:46 PM INVESTIGATION ALERT: The M&A Class Action Firm Inv... Source: N/A Oct 29, 2024 @ 10:10 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: N/A Oct 29, 2024 @ 5:18 PM GlycoMimetics Shares Are Soaring Tuesday: Here's W... Source: Dylan Berman Aug 14, 2024 @ 10:00 AM Apollomics Reports First Half 2024 Financial Resul... Source: Apollomics Inc. Financials   TTM Q4 2024 FY 2024 Basic EPS $-.59 $-.11 $-.59 Diluted EPS $-.59 $-.11 $-.59 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -37.88M $ -7.22M $ -37.88M Operating Income / Loss $ -40.04M $ -7.33M $ -40.04M Cost of Revenue $ $ $ Net Cash Flow $ -31.07M $ -3.67M $ -31.07M PE Ratio